Edwards Lifesciences | EW - 销售毛利

股票价格

81.26

每天变化

-1.02 -1.24%

每月一次

2.21%

每年

7.64%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 48.07B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	销售毛利	更改		日
Abbott	USD 5.86B		675M	2026-03
Artivion	USD 73.14M		1.25M	2025-12
AtriCure	USD 105.34M		4M	2025-12
Baxter International	USD 577M		373M	2025-12
Becton, Dickinson and Co.	USD 2.41B		1.72B	2025-12
Boston Scientific	USD 3.61B		64M	2026-03
Cooper Companies	USD 695.2M		44.4M	2025-12
Dexcom	USD 792.7M		61.3M	2025-12
Edwards Lifesciences	USD 1.29B		59.4M	2026-03
Globus Medical	USD 535.95M		49.28M	2025-12
ICU Medical	USD 202.98M		2.1M	2025-12
Inogen	USD 41.34M		1.39M	2024-09
Insulet	USD 568.6M		58.5M	2025-12
Integra LifeSciences	USD 217.1M		10.11M	2025-12
Intuitive Surgical	USD 1.83B		73.8M	2026-03
J&J	USD 17.24B		642M	2026-03
Masimo	USD 247.3M		16.7M	2025-12
Medtronic	USD 5.41B		27M	2025-12
Merit Medical Systems	USD 195.35M		8.94M	2025-12
Stryker	USD 4.49B		633M	2025-12
Tandem Diabetes Care	USD 167.46M		33.17M	2025-12
Teleflex	USD 307.45M		144.2M	2025-12
Zimmer Biomet Holdings	USD 1.27B		8.1M	2025-12